Market Place
Sourcing Support
Tetra Bio-Pharma Announces Listing to OTCPink Market
10 Feb 2023 //
PR NEWSWIRE
Tetra Bio-Pharma reports results from trial of ARDS-003 and Favipiravir
07 Dec 2022 //
CLINICALTRIALSARENA
Tetra Bio-Pharma Provides Update on Patent Applications for ARDS-003
29 Nov 2022 //
PRNEWSWIRE
Tetra Bio-Pharma Provides Update on Its REDUVO™ New Drug Submission
18 Nov 2022 //
PRNEWSWIRE
Tetra and Prepaire Jointly Apply to BARDA for Funding
11 Oct 2022 //
PRNEWSWIRE
ABO Announces a CAD 10M Financing Arrangement with TBP
14 Sep 2022 //
BUSINESSWIRE
Tetra Announces Revised Terms & First Closing of Financing with Alpha Blue Ocean
08 Sep 2022 //
PRNEWSWIRE
Tetra and Cellvera partner to develop oral Covid-19 treatment
07 Sep 2022 //
PHARMACEUTICAL-TECHNOLOGY
Tetra Bio-Pharma, Cellvera to Co-Develop Potential Oral Covid Treatment
06 Sep 2022 //
CONTRACTPHARMA
Tetra Bio-Pharma Announces Positive Preclinical Results of ARDS-003
10 Aug 2022 //
PR NEWSWIRE
Akanda to Supply Tetra Bio-Pharma with Cannabis for FDA Trials of QIXLEEF
12 Jul 2022 //
PRNEWSWIRE
Tetra Bio-Pharma opens new subsidiary in Australia
08 Jun 2022 //
BIOSPECTRUMASIA
Tetra Bio-Pharma Opens New Subsidiary in Australia & Provides Regulatory Update
06 Jun 2022 //
PRNEWSWIRE
Tetra Bio-Pharma Announces Voting Results of 2022 Annual General Meeting
31 May 2022 //
PRNEWSWIRE
Tetra Bio-Pharma Appoints Chief Financial Officer
30 May 2022 //
PRNEWSWIRE
Tetra Bio-Pharma Receives EMA ODD for Topical Therapeutic Containing CBD
18 May 2022 //
PRNEWSWIRE
Tetra Bio-Pharma Announces Closing of First Tranche with Cannvalate
17 May 2022 //
PRNEWSWIRE
Tetra Bio Signs License Agreement with Thorne for Prebiotic Dietary Supplement
22 Feb 2022 //
PRNEWSWIRE
Tetra Bio-Pharma Enters into a Strategic Partnership with Avicanna
14 Feb 2022 //
PRNEWSWIRE
Tetra Bio-Pharma Announces Pricing of Marketed Public Offering of Units
14 Dec 2021 //
GLOBENEWSWIRE
Tetra Bio-Pharma Announces+VE Initial Clinical Data from Both its Ongoing Ph 2
29 Nov 2021 //
BIOSPACE
Tetra reports positive data from Phase II trials of cancer pain drug
29 Nov 2021 //
CLINICALTRIALSARENA
Tetra Bio-Pharma Receives Positive Opinion for Orphan Drug for QIXLEEF™
21 Oct 2021 //
NOVOCURE
Tetra Bio-Pharma Provides Update on Clinical Development Program for QIXLEEF™
14 Oct 2021 //
PRNEWSWIRE
REDUVO™ - A Major Milestone for Tetra Bio-Pharma Inc.
05 Oct 2021 //
PRNEWSWIRE
Tetra Bio-Pharma Receives Positive Scientific Advice Assessment (SAA) Report
02 Sep 2021 //
PRNEWSWIRE
Tetra Bio-Pharma Files PCT Patent Application for Cannabis Plant Residue
29 Jul 2021 //
PRNEWSWIRE
Tetra Bio-Pharma Engages Christine Caron as Patient Partner
22 Jul 2021 //
PRNEWSWIRE
Tetra Bio-Pharma Engages Christine Caron as Patient Partner
22 Jul 2021 //
PRNEWSWIRE
Tetra Bio-Pharma Accelerates REBORN1© Trial
12 Jul 2021 //
PRNEWSWIRE
New Antiviral Properties of Tetra Bio-Pharma`s Innovative Drug ARDS-003
21 Jun 2021 //
PRNEWSWIRE
Tetra Bio-Pharma Accelerates PLENITUDE(C) Clinical Trial to Evaluate the Effect
11 May 2021 //
BIOSPACE
Tetra Bio-Pharma Announces $10 Million "Bought Deal" Public Offering
10 May 2021 //
NEWSWIRE
Tetra Bio-Pharma Announces Start of the REBORN1(C) Clinical Trial
06 May 2021 //
ACCESSWIRE
Tetra Bio-Pharma Signs a Definitive Distribution Agreement with DanCann
05 May 2021 //
ACCESSWIRE
Tetra Bio-Pharma submits request to Malta Medicines Authority
28 Apr 2021 //
PROACTIVEINVESTOR
Tetra Bio-Pharma Provides an Update on its U.S. REBORN1 Clinical Trial
23 Apr 2021 //
PRESS RELEASE
Tetra Bio-Pharma Announces Granting of U.S. Patent for Interstitial Cystitis
15 Apr 2021 //
BIOSPACE
Tetra Bio-Pharma initiates additional studies on lead drug candidate ARDS-003
26 Mar 2021 //
PROACTIVEINVESTORS
Tetra Bio-Pharma Inc. Announces $10 Million Bought Deal Offering of Units
22 Feb 2021 //
NEWSWIRE
Tetra Bio Pharma Announces Divestiture of Lumiera Health Innovation Inc.
28 Oct 2020 //
BIOSPACE
IntelGenx Enters Into Amended and Restated License Agreement with Tetra Bio
21 Oct 2020 //
GLOBENEWSWIRE
Tetra Bio-Pharma adds two board members; appoints new COO
17 Sep 2020 //
SEEKING ALPHA
Tetra Bio-Pharma and Dalton Pharma Enter GMP Manufacturing Tie-up
20 Aug 2020 //
CONTRACTPHARMA
FDA Provides Positive Feedback on Tetra Bio-Pharma`s Pre-iNDAfor ARDS-003
17 Jul 2020 //
PRESS RELEASE
Tetra Bio-Pharma Provides Update on PPP003 Inflammatory Cytokine
11 May 2020 //
YAHOO
Tetra Bio-Pharma Provides PPP003 Inflammatory Cytokine Reduction Drug Program
06 May 2020 //
YAHOO
Tetra Receives its 4th FDA Orphan Drug Designation
16 Apr 2020 //
ACCESSWIRE
Tetra Receives FDA Orphan Drug Designation for its Ophthalmic Clinical Program
15 Apr 2020 //
TETRABIOPHARMA
Tetra BioPharma Confirms QIXLEEF Clinical Site Receives Renewal of DEA 1 License
14 Apr 2020 //
PRESS RELEASE
Tetra Biopharma Confirms Type B Meeting Date With FDA Regarding HCC011
06 Apr 2020 //
PRESS RELEASE
Tetra Bio Pharma confirms Type B Meeting date with FDA on HCC01
06 Apr 2020 //
THEFLY
FDA Provides Positive Feedback on Tetra Bio-Pharma`s Application for ARDS-003
05 Apr 2020 //
BIOSPACE
Tetra Bio Pharma Announces Filing of Final Base Shelf Prospectus for up to $50 M
01 Apr 2020 //
NEWSWIRE
Shionogi boosts Tetra Alzheimer`s deal, nabs buyout option
06 Mar 2020 //
FIERCE BIOTECH
Tetra Bio-Pharma Announces Exercise of Over-Allotment Option
05 Mar 2020 //
FINANCE
Tetra Bio-Pharma Enters into Co-Development Agreement with MAKScientific
27 Feb 2020 //
GLOBENEWSWIRE
Tetra Bio-Pharma Provides Additional Information on QIXLEEF
24 Feb 2020 //
YAHOO
Tetra Bio-Pharma Provides Update on its Commercialization Plan for its OTC DIN
21 Jan 2020 //
GLOBENEWS WIRE
Tetra Bio-Pharma Granted Two OTC Drug Identification Numbers by Health Canada
18 Jan 2020 //
GLOBE NEWSWIRE
